secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001683168-25-001857
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma expands Microcyn distribution deal with WellSpring to include additional products
--------------------------------------------------------------------------------

- Amendment No. 1 dated March 21, 2025 adds new Microcyn-based products to existing Master Supply Agreement.
- Distributor exclusivity rights broadened per revised Attachment A; original agreement dated Jan 29, 2025.
- Upfront labeling fee per SKU required (amount redacted) upon initial purchase order for new products.
- Initial term remains two years with three automatic one-year renewals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825001857/0001683168-25-001857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825001857/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-001857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer